Metal Transport: Pumping iron
Thousands of proteins must bind to metal ions in order to function properly. Maintaining healthy amounts of metals in cells should be simple: cells have access to a large pool of metal ions and all they need to do, in principle, is to select the metal ions they need from this pool. The reality, however, is different: the pool of available metals is really an alphabet soup of essential nutrients, trace elements and deadly toxins, and the availability of the metals in this pool in no way matches the nutritional requirements of the organism. Cells must, therefore, take up and distribute the correct amounts of each metal they need, notably iron and zinc, but also many others.
Because they have an electric charge, metal ions cannot enter cells by simple diffusion, and instead require dedicated transport systems to help them cross cell membranes. Metal ion transporters are a diverse group of proteins embedded in the plasma membrane, or in the membranes of the organelles inside the cell, that can transport specific metal ions into and out of the cytosol.
Metal transporters can be grouped into families based on their amino acid sequence. All the members of a given family tend to transport similar metal ions, and usually pump ions in only one direction—either into or out of the cell. Now, in eLife, Bing Zhou and co-workers from Tsinghua University—including Guiran Xiao and Zhihui Wan as joint first authors—have found that a transporter called ZIP13 transports iron out of cells in fruit flies (Xiao et al., 2014).
High levels of nutrient metals can be toxic, so the activity of metal ion transporters is highly regulated. Sensors detect the levels of metal inside the cell, and in turn control the production and destruction of the transporters. However, this approach ultimately runs into an inherent limitation; the transporters themselves have a limited capacity to discriminate between different metal ions.
In the case of the ZIP family of metal ion transporters, the name—ZIP is short for Zrt-, Irt-like protein—is the first indication of this limited selectivity. Zrt proteins were first identified as zinc importers in a species of yeast (Zhao and Eide, 1996). Soon afterwards, a similar gene, Irt1, descended from an ancestor of Zrt, was identified in the plant species Arabidopsis thaliana as an iron importer (Eide et al., 1996). Subsequently, ZIP-family transporters that can transport iron and zinc have been identified in essentially all eukaryotic genomes, with more complex eukaryotes expressing many different copies of ZIP-family genes (Lye et al., 2012; Jeong and Eide, 2013).
Further study has demonstrated that, in addition to zinc and iron, many ZIP-family transporters can also transport other metal ions, such as manganese, copper, nickel and cadmium (Dempski, 2012). The biological role of the ZIP gene may also be determined by the conditions under which it is expressed: for example, zinc-transporting ZIPs are expressed under zinc-deficient conditions.
In humans and mice, a ZIP gene called Zip13—which is thought to specifically transport zinc—has been studied in detail because mutations in humans are associated with a form of Ehlers-Danlos syndrome, a connective tissue disorder (Giunta et al., 2008; Bin et al., 2011; Jeong et al., 2012). Now, Xiao, Wan and co-workers have examined dZip13—the fly gene most closely related to the human Zip13 gene—and found that it primarily transports iron rather than zinc.
Comparing flies depleted of dZip13 with wild type flies revealed that the depleted flies have a lower total amount of iron in their bodies, but normal amounts of zinc. The depleted flies are also less likely to emerge from the pupal stage than normal, and have shortened life spans. Both of these symptoms are improved by treating the flies with iron supplements. However, treating the flies with zinc supplements has no effect.
Given the numerous roles that ZIP family members play in iron transport, this is not very surprising. What is more remarkable is the evidence that dZip13 transports iron out of cells. This evidence came from vesicles called microsomes, which form from the membranes of the organelles that make up the secretory compartments, where proteins that are to be released from the cell are made.
Microsomes from flies lacking dZip13 exhibited reduced iron uptake rates. As an accumulation of iron within microsomes represents a flux of iron out of the cytosol, this suggests that dZip13 transports iron out of the cell. Similarly, microsomes that overexpressed dZip13 showed increased rates of iron uptake, suggesting an increased rate of iron transport out of the cell. Additionally, dZip13 was detected on intracellular vesicles when the transport protein was introduced to a human cell model. Combining this evidence led Xiao, Wan and colleagues to postulate that dZip13 primarily moves iron from the cytosol to the secretory compartment (Figure 1). There, the iron can be used to load ferritin, an iron-transporting protein in the fly circulatory system. This could be the solution to the long-standing mystery about how iron is moved from the cytosol to the secretory pathway in flies.

In the fruit fly Drosophila melanogaster, Zip13 transports iron into the secretory compartment.
Iron (pink circle) present in the diet of the fly is transported from the gut lumen into cells that line the gut (orange rectangle). Iron uptake is likely controlled by the Fe(II) transporter Mvl, which is similar to the human iron transporter DMT1. Iron in the cytosol may then be transported across the membranes of the endoplasmic reticulum or Golgi apparatus to the lumen of the secretory pathway: Xiao, Wan et al. have found that a protein called Zip13 is responsible for transporting the iron ions across these membranes. Once in the secretory pathway, the ions can be incorporated into the protein ferritin, which is then secreted into the hemolymph to carry iron to other cells in the fly (Mandilaras et al., 2013).
Is there precedent for ZIP transporters transporting ions in both directions? In yeast, genetic evidence suggests that one particular ZIP transporter may move zinc both into and out of vesicles inside the cell, depending on the amount of zinc present in the cytosol (Kumanovics et al., 2006). Several other families of transporter have also been shown to mediate both the uptake and release of metal ions from cells (Pao et al., 1998; Rees et al., 2009; Vert et al., 2009).
What do these results mean for the human disease related to Zip13 mutation? There is strong evidence that Zip13 primarily transports zinc—not iron—when expressed in human cells, and the data presented here do not refute those studies. Fly dZip13 is 45% identical to the human version. Expression of human ZIP13 in flies partially, but not completely, compensates for the loss of fly ZIP13. This suggests that human Zip13 may be able to transport iron to a limited extent.
Despite the genetic similarities and the common ancestor the fly and human transporters share, they may differ in their ability to transport particular metal ions. Perhaps the capacity to operate as both an importer and an exporter, to localize to different subcellular membranes, and to recognize multiple divalent metal cations, explains the evolutionary push to maintain so many copies of the ZIP proteins in eukaryotic genomes.
References
-
Biochemical characterization of human ZIP13 protein: a homo-dimerized zinc transporter involved in the spondylocheiro dysplastic Ehlers-Danlos syndromeJournal of Biological Chemistry 286:40255–40265.https://doi.org/10.1074/jbc.M111.256784
-
The cation selectivity of the ZIP transportersCurrent Topics in Membranes 69:221–245.https://doi.org/10.1016/B978-0-12-394390-3.00009-4
-
A novel iron-regulated metal transporter from plants identified by functional expression in yeastProceedings of the National Academy of Sciences of the USA 93:5624–5628.https://doi.org/10.1073/pnas.93.11.5624
-
Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome–an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13American Journal of Human Genetics 82:1290–1305.https://doi.org/10.1016/j.ajhg.2008.05.001
-
The SLC39 family of zinc transportersMolecular Aspects of Medicine 34:612–619.https://doi.org/10.1016/j.mam.2012.05.011
-
Promotion of vesicular zinc efflux by ZIP13 and its implications for spondylocheiro dysplastic Ehlers-Danlos syndromeProceedings of the National Academy of Sciences of the USA 109:E3530–E3538.https://doi.org/10.1073/pnas.1211775110
-
YKE4 (YIL023C) encodes a bidirectional zinc transporter in the endoplasmic reticulum of Saccharomyces cerevisiaeJournal of Biological Chemistry 281:22566–22574.https://doi.org/10.1074/jbc.M604730200
-
Systematic functional characterization of putative zinc transport genes and identification of zinc toxicosis phenotypes in Drosophila melanogasterJournal of Experimental Biology 215:3254–3265.https://doi.org/10.1242/jeb.069260
-
ABC transporters: the power to changeNature Reviews Molecular Cell Biology 10:218–227.https://doi.org/10.1038/nrm2646
-
The yeast ZRT1 gene encodes the zinc transporter protein of a high-affinity uptake system induced by zinc limitationProceedings of the National Academy of Sciences of the USA 93:2454–2458.https://doi.org/10.1073/pnas.93.6.2454
Article and author information
Author details
Publication history
Copyright
© 2014, Philpott
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,346
- views
-
- 90
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.